Norgesic Forte
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50991-999 -
Package NDC
50991-999-60 -
Application number
ANDA075141 -
SPL ID
472e3862-eab9-2279-e063-6394a90adb4c -
SPL set ID
85a3b808-b476-f2f0-e053-2a91aa0af21f -
UNII
X0A40N8I4S -
UNII
R16CO5Y76E -
UNII
3G6A5W338E -
RxCUI
994535 -
RxCUI
994537
What the source publishes
- Labeler
- Poly Pharmaceuticals, Inc.
- Active ingredients
- Orphenadrine Citrate, Aspirin and Caffeine
- Form
- TABLET, MULTILAYER
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Norgesic Forte",
"splId": "472e3862-eab9-2279-e063-6394a90adb4c",
"labels": [
{
"setId": "85a3b808-b476-f2f0-e053-2a91aa0af21f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85a3b808-b476-f2f0-e053-2a91aa0af21f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=85a3b808-b476-f2f0-e053-2a91aa0af21f"
}
],
"routes": [
"ORAL"
],
"labeler": "Poly Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, MULTILAYER in 1 BOTTLE (50991-999-60)",
"package_ndc": "50991-999-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20190401"
}
],
"productId": "50991-999_472e3862-eab9-2279-e063-6394a90adb4c",
"useDomain": "unknown",
"dosageForm": "TABLET, MULTILAYER",
"productNdc": "50991-999",
"deaSchedule": null,
"genericName": "Orphenadrine Citrate, Aspirin and Caffeine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ORPHENADRINE CITRATE",
"strength": "50 mg/1"
},
{
"name": "ASPIRIN",
"strength": "770 mg/1"
},
{
"name": "CAFFEINE",
"strength": "60 mg/1"
}
],
"applicationNumber": "ANDA075141",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190401",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000160",
"N0000008836",
"M0001335",
"N0000175722",
"N0000175578",
"N0000008832",
"N0000175739",
"N0000175729",
"N0000175790",
"M0023046"
],
"unii": [
"X0A40N8I4S",
"R16CO5Y76E",
"3G6A5W338E"
],
"rxcui": [
"994535",
"994537"
],
"spl_set_id": [
"85a3b808-b476-f2f0-e053-2a91aa0af21f"
],
"pharm_class_cs": [
"Anti-Inflammatory Agents, Non-Steroidal [CS]",
"Xanthines [CS]"
],
"pharm_class_pe": [
"Decreased Prostaglandin Production [PE]",
"Decreased Platelet Aggregation [PE]",
"Central Nervous System Stimulation [PE]"
],
"pharm_class_epc": [
"Nonsteroidal Anti-inflammatory Drug [EPC]",
"Platelet Aggregation Inhibitor [EPC]",
"Central Nervous System Stimulant [EPC]",
"Methylxanthine [EPC]"
],
"pharm_class_moa": [
"Cyclooxygenase Inhibitors [MoA]"
],
"manufacturer_name": [
"Poly Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50991-999_472e3862-eab9-2279-e063-6394a90adb4c"